M&A

M&A

JB Chemicals to buy probiotic, reproductive brands from Sanzyme for Rs.628-Cr

Economic Times  

KKR-controlled drug maker JB Chemicals & Pharmaceuticals Limited (JBCPL), will acquire probiotics and reproductive brands for the Indian market from Sanzyme Pvt Ltd for INR 628 crore. The acquired portfolio includes Sporlac which is the third largest probiotics brand in India and specialized products such as Lobun - a probiotic used for delaying progression of Chronic Kidney Disease and Oxalo - an alternative risk-free therapy to decalcify kidney stones. The reproductive health segment has a range of infertility and hormone products. The revenue for the combined brands is estimated to be about INR 160 crore. The acquired brands have a pan-India presence and wide distribution reach of 300,000 chemists and 100,000 prescribers.